Hemodialysis and Peritoneal Dialysis Market

The global Hemodialysis and Peritoneal Dialysis market size was USD 101.8 billion in 2023, and is calculated at USD 108.32 Billion in 2024. The market is projected to reach USD 189.31 Billion by 2034, and register a revenue 6.4% over the forecast period (2025-2034).

Premium Insights:

The global Hemodialysis and Peritoneal Dialysis market is expected to continue to register rapid revenue growth over the forecast period, driven by increasing prevalence of End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD), which are further magnified by rising rates of diabetes and hypertension. Also, rapidly aging global population is contributing to the steadily expanding patient base, as elderly individuals are more susceptible to kidney-related health issues, and require care, treatment, and assistance. Advances in dialysis technology, such as portable and home-based dialysis machines, are enhancing treatment convenience and accessibility, are leading to higher adoption rates among patients seeking flexible options.

In addition, supportive government policies and improved healthcare infrastructure, particularly in emerging markets, are expanding access to dialysis treatments. This, combined with greater awareness about kidney health and early diagnosis, is encouraging more patients to seek treatment earlier, which is also positively impacting market growth. Increasing investments in research and development are leading to innovations in dialysis solutions, including biocompatible materials and less invasive treatment options, which improve patient outcomes and reduce side effects.

Moreover, rising demand for personalized treatment plans and the growing role of telemedicine in dialysis care management are further supporting market growth. Expanding reimbursement coverage and a strong focus on cost-effective dialysis solutions are expected to sustain growth in the coming years, particularly in regions with a high burden of CKD and ESRD.

Hemodialysis enables removal of waste and excess fluids by circulating blood through an external machine equipped with a dialyzer, often performed in specialized centers or at home using advanced portable systems. Peritoneal dialysis, on the other hand, uses the patient’s peritoneum as a natural filter, offering the flexibility of self-administration at home. This approach includes methods such as Continuous Ambulatory Peritoneal Dialysis (CAPD) and Automated Peritoneal Dialysis (APD), providing a more independent lifestyle for patients.

Key advancements are transforming these treatments, including portable hemodialysis machines, biocompatible dialyzer materials, and user-friendly, home-based dialysis devices that improve accessibility and patient outcomes. Technological innovations, such as automated water disinfection systems and telemedicine integration, support higher treatment efficacy, safety, and monitoring. Furthermore, personalized dialysis solutions, driven by data analytics and Machine Learning (ML), are emerging as promising trends, tailoring treatments to individual needs. These advancements are reducing complications and improving quality of life of patients.

More recently, increased investments in dialysis infrastructure, expanding home-based options, and telehealth applications have led to better patient compliance and outcomes. With rising demand for cost-effective, flexible, and accessible treatment solutions, the Hemodialysis and Peritoneal Dialysis market is expected to continue to register significant growth. Also, advancements and research are resulting in emergence of offerings that enhance essential care for an expanding patient population.

Top Hemodialysis and Peritoneal Dialysis Market Drivers and Trends:

• Rising Prevalence of Kidney Diseases: Increasing incidence of chronic kidney disease and end-stage renal disease globally, often exacerbated by aging populations and high rates of diabetes and hypertension, has led to a surge in demand for dialysis. These treatments are essential for managing CKD and ESRD, as they remove toxins, manage fluid levels, and help maintain patient health. This expanding patient base is driving need for treatments, in various settings, and supporting growth of the market to a major extent.
• Advances in Technology and Equipment: Technological innovation in dialysis systems, such as biocompatible dialyzers, portable dialysis machines, and automated peritoneal dialysis devices, enhances treatment efficacy, safety, and patient convenience. These advancements reduce the likelihood of complications, improve the user experience, and support homecare applications, making dialysis treatment more accessible and appealing. Integration of digital health monitoring and telemedicine further supports the remote management of dialysis patients, promoting wider adoption and market growth.
• Growing Preference for Home-Based Dialysis: The shift toward home-based Hemodialysis and Peritoneal Dialysis is gaining momentum, as patients increasingly seek treatments that align with a flexible, independent lifestyle. This trend is reinforced by the increasing availability of user-friendly, compact, and automated home dialysis systems, along with supportive healthcare policies and insurance coverage. Home-based dialysis reduces the need for frequent hospital visits, lowers costs for healthcare providers, and offers patients more autonomy and comfort, which are key factors accelerating demand.
• Expanding Healthcare Infrastructure and Supportive Policies: Increasing investments in healthcare infrastructure and supportive government initiatives, especially in emerging markets, are facilitating access to dialysis treatment. These initiatives address the growing need for dialysis services and are complemented by healthcare policies that enhance reimbursement rates and reduce financial barriers to treatment. Also, rising awareness about kidney health and the availability of early diagnostic tools are prompting more timely intervention, driving greater adoption of dialysis solutions.

Hemodialysis and Peritoneal Dialysis Market Restraining Factor Insights

• High Treatment Costs: The cost of both Hemodialysis and Peritoneal Dialysis remains a significant barrier, especially in low- and middle-income regions. The need for specialized equipment, disposable components, and the ongoing expense of dialysis sessions - often multiple times per week - makes these treatments financially overbearing. Despite insurance coverage in many regions, out-of-pocket costs for patients and healthcare systems can be prohibitive. This financial strain limits access to dialysis for a large portion of the global population, particularly in emerging markets.
• Complications and Risks Associated with Dialysis: Both Hemodialysis and Peritoneal Dialysis carry potential risks, such as infections, blood pressure fluctuations, catheter-related complications, and long-term vascular damage. Infections related to peritoneal dialysis, such as peritonitis, and issues with vascular access in hemodialysis, like clotting or thrombosis, remain major concerns. These complications often require additional interventions or hospitalization, leading to higher overall costs and impacting patient outcomes. The potential for long-term side effects and complications can deter some patients from opting for dialysis treatments.
• Limited Access to Healthcare Infrastructure: The number of dialysis centers and home care treatments is increasing, but significant disparity remains in terms of access to these services, particularly in rural areas or less developed regions. Insufficient healthcare infrastructure, inadequate medical personnel, and lack of proper training for at-home dialysis management prevents many patients from receiving timely treatment. This lack of access to care limits the patient pool and poses a challenge for global market expansion. Also, research and development efforts to enhance treatment modalities may be restrained by lack of funding in certain regions, thereby slowing innovation and adoption.

Hemodialysis and Peritoneal Dialysis Market Opportunities

• Expansion of Home-Based Dialysis Solutions: Increasing demand for at-home dialysis is prompting machine and system manufacturers to focus on developing compact, user-friendly, and automated dialysis devices that cater to home care settings. Offering more flexible and less invasive solutions can create a new revenue stream as more patients opt for the independence and convenience of home dialysis. Partnering with healthcare providers for direct-to-consumer models could further ease market penetration.
• Advanced Water Treatment and Monitoring Systems: Rising demand for high-quality water for dialysis treatments presents an opportunity for manufacturers to innovate in water treatment systems. Developing automated, more efficient water purification and monitoring systems can improve treatment outcomes, reduce complications, and enhance patient safety, creating additional demand for dialysis centers and home care settings.
• Strategic Collaborations, Mergers, and Acquisitions: Manufacturers can expand their market footprint through partnerships, acquisitions, or joint ventures with regional players or healthcare providers. This approach would allow for improved distribution networks, access to new customer segments, and enhanced R&D capabilities. Investing in new product development, particularly in biocompatible dialysis solutions and wearable dialysis technologies, will allow companies to lead in emerging trends.

Hemodialysis and Peritoneal Dialysis Market Segmentation:

Hemodialysis Market Segmentation:

By Product Type:

• Hemodialysis Machines
• Dialyzers
• Bloodline Systems
• Water Treatment Systems
• Concentrates & Solutions
• Other Accessories and Consumables

By Treatment Setting:

• In-Center Hemodialysis
• Home Hemodialysis

By Modality:

• Conventional Hemodialysis
• Short Daily Hemodialysis
• Nocturnal Hemodialysis

By End User:

• Hospitals
• Dialysis Centers & Clinics
• Homecare Settings

Peritoneal Dialysis Market Segmentation:

By Product Type:

• Peritoneal Dialysis Machines
• Concentrates & Solutions
• Catheters & Tubes
• Other Accessories

By Treatment Type:

• Continuous Ambulatory Peritoneal Dialysis (CAPD)
• Automated Peritoneal Dialysis (APD)

By Modality:

• Continuous Peritoneal Dialysis
• Intermittent Peritoneal Dialysis

By End User:

• Hospitals
• Dialysis Centers & Clinics
• Homecare Settings

Segment Insights:

Hemodialysis Market Segment Insights:

By Product Type:

The dialyzers segment is expected to account for largest revenue share among the product type segments in the hemodialysis market over the forecast period. Dialyzers are engineered to function as artificial kidneys, and are essential in filtering waste and excess fluid from the blood in the absence, disease, damage, or malfunction of actual kidneys. The recurring use in each dialysis session creates a steady demand, especially as dialysis frequency and patient numbers increases globally. Technological advancements, such as high-flux dialyzers and improved membrane biocompatibility, are enhancing treatment efficacy and patient safety, and further driving adoption. The high replacement rate and increased awareness about biocompatible materials also support sustained demand.

By Treatment Setting:

The in-center hemodialysis segment leads in terms of revenue share among the treatment setting segments due to high availability of structured care environments staffed with trained medical professionals. Provision of immediate support enabling safer management of complications that may arise during sessions makes these in-center facilities highly preferred. Patients, especially those with severe CKD or ESRD, typically prefer in-center treatment for safety and more streamlined care and reduced at-home responsibility. Also, in-center dialysis is widely covered by insurance, reducing out-of-pocket expenses. Rising investment in dialysis infrastructure, especially in high-demand areas, is further increasing in-center capacity and supporting revenue growth of this segment.

By Usage:

The conventional hemodialysis segment is expected to dominate the usage segment in terms of revenue share over the forecast period. This can be largely attributed to this being the standard and most widely adopted hemodialysis method. Typically performed three times a week, this modality offers a balance between efficacy and practicality for most patients, especially those who require regular, ongoing treatment. Conventional hemodialysis is readily available in most dialysis centers, making it highly accessible. It is also commonly covered by healthcare payers, which helps sustain patient adherence. In addition, the familiarity with conventional hemodialysis among clinicians and patients reinforces its position as the primary treatment approach in many countries.

By End User:

The dialysis centers & clinics segment is projected to account for largest revenue share among the end-user segments in the hemodialysis market over the forecast period. This can be attributed to specialization in dialysis care and dedicated focus on renal treatment in these settings. These centers are equipped also with advanced technology, enabling efficient handling of a high patient volumes. Dialysis centers typically offer a range of options, including both in-center and home hemodialysis support, meeting diverse patient needs. In addition, government and private sector investments in expanding dialysis centers, particularly in underserved and urban areas, are enhancing accessibility.

Peritoneal Dialysis Market Segment Insights:

By Product Type:

The concentrates & solutions segment is expected to account for largest revenue share among the product type segments in the peritoneal dialysis market over the forecast period. These solutions are essential for the dialysis process, requiring frequent replacement in each treatment session. As the number of patients on peritoneal dialysis increases, consumption of these solutions, particularly biocompatible ones that minimize inflammation and improve patient comfort incline in parallel. Also, advancements in solution formulations and rising awareness regarding the benefits of these enhanced options are further driving revenue growth within this segment.

By Treatment Type:

The continuous Ambulatory Peritoneal Dialysis (CAPD) segment is expected to dominate the treatment type segments over the forecast period. This can be attributed to flexibility and independence, allowing patients to manage treatment themselves at home without needing machinery. CAPD appeals to patients who seek convenience and want to maintain an active lifestyle, as it provides freedom to perform daily activities. The rising awareness of home-based dialysis options and the low operational costs compared to in-center treatments also contribute to CAPD’s growing adoption. Insurance coverage for CAPD and the reduced reliance on healthcare professionals further support its expansion, making it the preferred peritoneal dialysis method globally.

By Usage:

The continuous peritoneal dialysis segment is expected to continue to account for largest revenue share among the usage segment over the forecast period. Continuous peritoneal dialysis offers consistent waste removal, which is beneficial for maintaining patient stability and reducing symptom fluctuations. Continuous dialysis is also preferred over intermittent types because of its stable results and better fluid balance, which contribute to improved quality of life. Continuous peritoneal dialysis can also be performed at home, which makes it both convenient and cost-effective.

By End User:

The homecare settings segment among the end-user segments is expected to lead in terms of revenue share over the forecast period. Preference for home-based dialysis treatment is convenient for patients and is particularly popular among those who want to avoid frequent hospital or clinic visits and manage their condition in a familiar environment. Technological advancements, such as user-friendly machines and delivery services for dialysis supplies, support this trend, making at-home treatment easier. Also, cost savings for healthcare systems and expanding insurance coverage for home-based dialysis are further expected to contribute to revenue growth of the homecare settings segment over the forecast period.

‹›

Report Coverage & Deliverables

PDF report & online dashboard will help you understand:

• Real-Time Data Updates:
• Competitor Benchmarking
• Market Trends Heatmap
• Custom Research Queries
• Market Sentiment Analysis
• Demographic and Geographic Insights

Book Demo

Get Access Now

Track market trends LIVE & outsmart rivals with our Premium Data Intel Tool: Vantage Point

Regions and Countries

North America

• United States
• Canada
• Mexico

Europe

• Germany
• United Kingdom
• France
• Italy
• Spain
• Rest of Europe

Asia Pacific

• China
• Japan
• India

Rest of Asia Pacific

• Latin America
• Brazil
• Argentina

Rest of Latin America

• Middle East & Africa
• Saudi Arabia
• South Africa
• United Arab Emirates
• Israel
• Rest of MEA

Hemodialysis and Peritoneal Dialysis Market Regional Landscape:

Among the regional markets in 2023, the North America Hemodialysis and Peritoneal Dialysis market maintained dominance in terms of revenue share. Among the country-level markets in the region, the US accounted for majority revenue share contribution, driven by a high prevalence of chronic kidney disease and end-stage renal disease, coupled with advanced healthcare infrastructure and favorable reimbursement policies. Strong presence of leading companies catering to a well-established dialysis market with a focus on both in-center and home dialysis solutions also contribute significantly to growth of the North America market.

In Europe, countries such as Germany, France, and the UK are major revenue contributors to the market, supported by well-regulated healthcare systems and government support for dialysis treatments. Presence of companies such as Baxter International (U.S.) and Fresenius Medical Care offering advanced dialysis systems to healthcare providers in countries in the region, particularly focusing on patient-centric technologies and home dialysis adoption, is also a major factor supporting market growth.

Asia Pacific Hemodialysis and Peritoneal Dialysis market revenue growth has been increasing rapidly, with China and India being major contributors due to rising prevalence of diabetes and hypertension, and a growing middle class with better access to healthcare. Also, adoption of both Hemodialysis and Peritoneal Dialysis is rising in these countries as government initiatives improve healthcare access and affordability.

Hemodialysis and Peritoneal Dialysis markets in Latin America and the Middle East & Africa are also gaining traction due to improved healthcare investments, though these markets still face challenges related to healthcare infrastructure. Companies such as Medtronic (Ireland) are expanding footprint to cater to these regions, with focus on affordable dialysis solutions and local partnerships expected to have positive impacts.

Hemodialysis and Peritoneal Dialysis Market Competitive Landscape:

Company List:

• DaVita Inc.
• Baxter
• B. Braun SE
• Diaverum
• Nipro Europe Group Companies
• Nxstage Medical, Inc.
• Nikkiso Co., Ltd.
• Evoqua Water Technologies LLC
• Asahi Kasei Medical Co., Ltd.
• Rockwell Medical, Inc.
• Medtronic
• Dialifegroup
• JMS Co. Ltd.
• 3M
• Allmed Medical Care Holdings Limited

Competitive Landscape:

The global Hemodialysis and Peritoneal Dialysis market is highly competitive, with a number of leading companies dominating the landscape. Major companies such as Fresenius Medical Care, DaVita Inc., Baxter International, Medtronic, and Nipro Corporation lead among the companies in the market, offering a wide range of products, including hemodialysis machines, dialyzers, and peritoneal dialysis solutions. These companies are constantly innovating to meet the growing demand for more efficient, convenient, and cost-effective dialysis treatments.

Companies are investing in Research and Development (R&D) to introduce advanced dialysis systems with enhanced efficiency, biocompatibility, and user-friendliness. A key focus is on home-based dialysis solutions, which cater to the increasing demand for more independent, patient-centered care. For example, Fresenius and Baxter have developed automated systems and portable dialysis machines to facilitate at-home treatments, offering greater convenience for patients.

Leading players are also forming strategic alliances with healthcare providers, hospitals, and local distributors to expand their market reach, especially in emerging regions like Asia Pacific and Latin America. DaVita has successfully expanded its footprint globally through acquisitions and partnerships with local dialysis centers. Companies are also focusing on expanding into untapped markets by enhancing local production capabilities, tailoring products to regional needs, and collaborating with governments to improve healthcare infrastructure.

Recent Developments

• August 13, 2024: Baxter International Inc., which is a leading player in the global medtech sector, entered into a definitive agreement with Carlyle), which is a global investment firm, for the sale of its Kidney Care segment. This segment, which will be renamed Vantive, is valued at US$ 3.8 billion, and Carlyle’s investment in Vantive is part of a partnership with Atmas Health, which is an entity formed in September 2022 by a group of executives to focus on acquiring and growing market-leading healthcare businesses. This transaction, set to close in late 2024 or early 2025 following regulatory approval, aligns with Baxter’s strategic realignment aimed at enhancing performance and creating value, and also highlights Baxter's focus on enhancing its specialized Kidney Care segment.
• August 22, 2024: Fresenius Medical Care (FME), which is a global leader in kidney care, has reached a significant milestone with over 14,000 patients in the US now utilizing its NxStage systems for Home Hemodialysis (HHD) therapy. This achievement spans both Fresenius Kidney Care clinics and other healthcare providers. Also, the company has introduced the latest version of its home dialysis machine, the NxStage Versi HD, now equipped with GuideMe Software. This new version includes several updates designed to streamline treatment, improve the learning process, and enhance the overall user experience. These advancements demonstrate the reliability and effectiveness of the NxStage system in providing safe, high-quality care to patients within the comfort of their homes. From January to April 2024, the number of new HHD patients starting treatment with NxStage in the US saw an 18% increase compared to the same period in 2023.
• August 22, 2024: A team of researchers from UNC-Chapel Hill announced a project focused on developing innovative membrane technology aimed at significantly shrinking dialysis equipment, making it more convenient and accessible for patients worldwide. The researchers are working to create highly efficient membranes that could enable a portable dialysis device, potentially as small as a smartphone. This project, named ‘Graphene Oxide Membranes for Portable Kidney Dialysis’ (GENESIS), envisions a device that would function using the body’s natural blood pressure and lightweight disposable cartridges. The long-term goal is to provide continuous dialysis, allowing patients to undergo treatment around the clock while maintaining their everyday activities and minimizing the need for regular clinic visits.

Frequently Asked Questions:

Q: What is the global Hemodialysis and Peritoneal Dialysis market size in 2024 and what is the projection for 2034?

A: The global Hemodialysis and Peritoneal Dialysis market size was calculated at USD 108.32 billion in 2024 and expected to reach USD 189.31 billion in 2034

Which regional market accounted for largest revenue share in 2023, and what is the expected trend over the forecast period?

A: North America is expected to account for largest revenue share in the global market over the forecast period.

Q: Which are the major companies are included in the global Hemodialysis and Peritoneal Dialysis market report?

A: Major companies in the market report are DaVita Inc., Baxter, B. Braun SE, Diaverum, Nipro Europe Group Companies, Nxstage Medical, Inc., Nikkiso Co., Ltd., Evoqua Water Technologies LLC, Asahi Kasei Medical Co., Ltd., Rockwell Medical, Inc., Medtronic, Dialifegroup, JMS Co. Ltd., 3M, Allmed Medical Care Holdings Limited, Isopure Corp.

Q: What is the projected revenue CAGR of the global Hemodialysis and Peritoneal Dialysis market over the forecast period?

A: The global Hemodialysis and Peritoneal Dialysis market is expected to register a CAGR of 6.4% between 2025 and 2034.

Q: What are some key factors driving revenue growth of the Hemodialysis and Peritoneal Dialysis market ?

A: Some key factors driving market revenue growths are increasing prevalence of End-Stage Renal Disease (ESRD) and Chronic Kidney Disease (CKD), rising rates of diabetes and hypertension, rapidly aging global population, and expanding patient base with kidney-related health issues.